Houlihan Lokey, Inc.
NYSE-HLI
Company Overview
Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as advise financial sponsors on various transactions. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial and Valuation Advisory segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, and solvency opinions in connection with corporate spin-offs and dividend recapitalizations; and other types of financial opinions. In addition, this segment offers dispute resolution services. It serves corporations, institutions, and governments. The company was incorporated in 1972 and is headquartered in Los Angeles, California with offices in the United States, Europe, the Middle East, and the Asia-Pacific region.
Name
Houlihan Lokey, Inc.
CEO
Mr. Scott Joseph Adelson
Website
hl.com
Sector
Capital Markets
Year Founded
1972
Profile
Market Cap
$10.76B
EV
—
Shares Out
69.53M
Revenue
$2,011.97M
Employees
2,601
Margins
Gross
93.51%
EBITDA
—
Operating
—
Pre-Tax
20.58%
Net
15.3%
FCF
16.68%
Returns (5Yr Avg)
ROA
13.18%
ROTA
26.13%
ROE
21.9%
ROCE
—
ROIC
19.74%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$148
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$449.7M
Net Debt
-$14.5M
Debt/Equity
0.24
EBIT/Interest
—
Growth (CAGR)
Rev 3Yr
6.06%
Rev 5Yr
12.55%
Rev 10Yr
12.44%
Dil EPS 3Yr
-3.98%
Dil EPS 5Yr
11.47%
Dil EPS 10Yr
14.62%
Rev Fwd 2Yr
15.15%
EBITDA Fwd 2Yr
21.39%
EPS Fwd 2Yr
21.29%
EPS LT Growth Est
17%
Dividends
Yield
—
Payout
46.62%
DPS
$2.22
DPS Growth 3Yr
16.06%
DPS Growth 5Yr
14.66%
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
3.89%